Factors Controlling Pharmacokinetics of Intravenously Injected Nanoparticulate Systems
- 1 January 2009
- book chapter
- Published by Springer Nature
- p. 267-282
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Targeting of nanoparticles to the clathrin-mediated endocytic pathwayBiochemical and Biophysical Research Communications, 2007
- Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescenceProceedings of the National Academy of Sciences, 2006
- The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouseBiochemical and Biophysical Research Communications, 2005
- The role of β2-glycoprotein I in liposome–hepatocyte interactionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Cellular Distribution of Nonionic MicellesScience, 2004
- PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performanceFEBS Letters, 2002
- Exploiting bone marrow microvascular structure for drug delivery and future therapiesAdvanced Drug Delivery Reviews, 1995
- The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrowFEBS Letters, 1992
- Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coatingBiochemical and Biophysical Research Communications, 1991
- Primate erythrocyte-immune complex-clearing mechanism.Journal of Clinical Investigation, 1983